Empirical antibiotic treatment requires good insight in the prevalance of antimicrobial resistance (AMR). Conventional prevalence surveys are time consuming, costly, and provide aggregated estimates. The presentation introduces the LQAS methodology to rapidly classify well-defined populations as having high- or low prevalence of AMR, facilitating appropriate antibiotic treatment strategies at a local level.
VS-CNV Annotations from the User's PerspectiveGolden Helix
Next-generation sequencing has enabled clinicians and researchers alike to identify novel genetic variants associated with rare Mendelian Diseases across the human genome. To help enable researchers and clinicians understand the role of CNVs in human health and disease, Golden Helix has a fully integrated CNV annotations to provide clinicians and researchers with more effective methods to identify pathogenic CNVs for heritable diseases. In this webcast, we will present our comprehensive clinical workflows that integrates the annotating and reporting of high-quality CNV alongside their existing NGS variants.
One of the main challenges for a versatile application of monitoring technologies in the
veterinary and food industry is to develop fast, quantitative and low cost devices that
can be used with minimal expertise. Most of the diagnostic technologies in use today
require laboratory facilities, expensive equipments and trained personnel. During the
last decade, a few technologies have been proposed and developed that fulfill most
requirements of versatility mentioned above. One of the most promising approaches is
the lateral flow immunoassay technique.
Performing a Trio Analysis in VSClinicalGolden Helix
We recently have exposed the powerful application of our newly released product, VSClinical and the included ACMG Guidelines. Our previous webcasts covered some basics on new algorithms and annotations behind the variant scoring and classification. Taking a step back for a moment, there are many long-time VarSeq users are familiar with our Trio template that comes packaged with the software. But, how does the Trio analysis fit into VSClinical?
In this webcast, we are going to explore some modifications to our baseline trio template showing how to incorporate the ACMG classification results into the various workflows. This will include capturing de novo, compound heterozygous, and dominant heterozygous variants. We will score criteria related to variant frequency, gene impact, and available study information. Additionally, we will also investigate the clinical section of the ACMG guideline tool to see how to leverage the inheritance and allelic state of each variant. After this webcast, the user will discover new avenues of examining trio data by utilizing the ACMG classifier to improve upon one of our classic templates.
Bioanalytical Capabilities -- Thought-Leading Science Armed with the Latest T...Covance
Helping your drug development program succeed is what we do. Keeping your timeline on track requires scientific expertise, operational experience and up-to-date knowledge of the regulatory environment. Whether you need preclinical or clinical bioanalysis, local support or global capabilities, Covance is the partner that you can trust to help deliver on your bioanalytical timelines every day, every time.
VS-CNV Annotations from the User's PerspectiveGolden Helix
Next-generation sequencing has enabled clinicians and researchers alike to identify novel genetic variants associated with rare Mendelian Diseases across the human genome. To help enable researchers and clinicians understand the role of CNVs in human health and disease, Golden Helix has a fully integrated CNV annotations to provide clinicians and researchers with more effective methods to identify pathogenic CNVs for heritable diseases. In this webcast, we will present our comprehensive clinical workflows that integrates the annotating and reporting of high-quality CNV alongside their existing NGS variants.
One of the main challenges for a versatile application of monitoring technologies in the
veterinary and food industry is to develop fast, quantitative and low cost devices that
can be used with minimal expertise. Most of the diagnostic technologies in use today
require laboratory facilities, expensive equipments and trained personnel. During the
last decade, a few technologies have been proposed and developed that fulfill most
requirements of versatility mentioned above. One of the most promising approaches is
the lateral flow immunoassay technique.
Performing a Trio Analysis in VSClinicalGolden Helix
We recently have exposed the powerful application of our newly released product, VSClinical and the included ACMG Guidelines. Our previous webcasts covered some basics on new algorithms and annotations behind the variant scoring and classification. Taking a step back for a moment, there are many long-time VarSeq users are familiar with our Trio template that comes packaged with the software. But, how does the Trio analysis fit into VSClinical?
In this webcast, we are going to explore some modifications to our baseline trio template showing how to incorporate the ACMG classification results into the various workflows. This will include capturing de novo, compound heterozygous, and dominant heterozygous variants. We will score criteria related to variant frequency, gene impact, and available study information. Additionally, we will also investigate the clinical section of the ACMG guideline tool to see how to leverage the inheritance and allelic state of each variant. After this webcast, the user will discover new avenues of examining trio data by utilizing the ACMG classifier to improve upon one of our classic templates.
Bioanalytical Capabilities -- Thought-Leading Science Armed with the Latest T...Covance
Helping your drug development program succeed is what we do. Keeping your timeline on track requires scientific expertise, operational experience and up-to-date knowledge of the regulatory environment. Whether you need preclinical or clinical bioanalysis, local support or global capabilities, Covance is the partner that you can trust to help deliver on your bioanalytical timelines every day, every time.
Title: Diagnostics in Veterinary Oncology
Presented by: Ariana Verrilli, DVM, DACVIM (Oncology)
Description: This session will discuss the various tests currently available in veterinary oncology, from cytology and histopathology to DNA sequencing and genetic testing. We will review the pros and cons of multiple tests, the best use for each test, and how to interpret results. We will also review sample submissions and specific lab requirements as appropriate.
AMP-Based Variant Classification with VSClinicalGolden Helix
Evaluating somatic variants according to the cancer AMP guidelines can be an extensive process. In addition to the standard collection of all available, clinical evidence for any biomarkers, there is a need to define treatment options following final classification. Even the most adept clinicians familiar to the guidelines suffer from this arduous process and thus need a standardized approach for classifying, interpreting and reporting variants according to the AMP guidelines. VSClinical’s new AMP workflow alleviates these complexities by providing an automated workflow that captures and reports on all critical data present. With the VSClinical AMP workflow, users can also customize clinical reports to reflect your lab’s preferences and branding. This webcast will provide a simple AMP guideline-based demonstration from a user perspective with multiple examples of simple report customizations from the VSClinical interpretation hub.
What you will learn in this webcast:
How VSClinical integrates the tier system to evaluate somatic mutations according to the AMP guidelines, with a focus on SNPs, InDels, CNVs and fusions
Automating the AMP guidelines using Golden Helix CancerKB and lab-specific knowledge databases to streamline variant classifications
Multiple report examples to demonstrate simple Word-based report customization capability
Overall, VSClinical enables labs to test for both germline and somatic variants according to the ACMG and AMP guidelines in an automated fashion and allows users to obtain consistent and accurate results.
Using reference materials to meet validation & verification requirements for ...Candy Smellie
Bio-Specimens used in Molecular Diagnostics
Most clinical tissue samples are preserved in FFPE
FFPE samples are now being used for molecular diagnostic testing
FFPE based studies: every specimen is different in terms of % tumor contribution to the specimen and % mutation contribution to the tumor
External Quality Assessment Proficiency Testing Scheme
Therapeutic choices are made based upon these results
False positive and false negative results are detrimental to the patient
Validation occurs across multiple areas of the clinical laboratory. Validation can include equipment, reagents, operators, platforms. Two of the key areas are test and platform validation.
Test development includes:
Establishing protocol
Optimising performance
Determining pooling parameters
Using synthetic variants to compare tools and facilitate optimisation
Test validation includes:
Determine parameters
First tests developed carry highest validation requirements
Changes to tests must follow re-validation required against existing test
Platform validation
Cumulative performance data established
Determine confidence intervals
Track and validate software versions
Changes to platform must follow re-validation required against existing platform
Is insourcing NGS testing worth it?
Dartmouth-Hitchcock has experienced nearly 40% savings by bringing NGS testing in-house. A recent AMP study using non-small cell lung cancer as an example cites $2.7 million in anticipated savings.
In-house NGS testing is the foundation of any modern precision medicine program. It can have a profound effect on patient care. And, as these examples show, a strong business case can be made.
How have Dartmouth-Hitchcock and other progressive institutions been so successful despite myriad challenges?
Join us for a webinar on May 31st at 12pm ET as Eric Loo, MD (Dartmouth-Hitchcock) and Rakesh Nagarajan, MD, PhD (PierianDx) explore answers to this question and more.
In this webinar you will learn:
How recent precision medicine trends are driving strong market growth for clinical NGS and other complex molecular testing.
How to make a strong business case for in-house NGS testing.
Challenges your institution is likely to face by insourcing.
Blueprints for overcoming these challenges, including reimbursement.
Living in a world of federated knowledge challenges, principles, tools and ...Valery Tkachenko
Over years a multitude of chemical formats and approaches were created to address various aspects of handling chemical information and building databases of chemical knowledge. As a result the current state of this landscape is severely affected by the lack of well-accepted and community-recognized formats, protocols, metadata standards, validation routines and standards in handling, storing and representation, lack of open toolkits which conform to the same standards as well as the lack of platforms which allow interactive and collaborative work to solve all the above problems. While such organizations as RDA and IUPAC as well as some government agencies and institutes are concerned and trying to address the problem it is still a severe pain point. In this presentation we will talk about our experience of building a federated knowledgebase called Open Science Data Repository which supports deposition of raw and structured chemical and analytical data in various formats, runs validation and standardization protocols, is build in a highly modular way that allows using both its API and its components in a Cloud or to be deployed on premises behind firewalls and supports a variety of use cases including collaborative data curation, rich analytics and visualization, real-time machine learning, formats conversion and preparing depositions into PubChem and ChemSpider from a variety of sources and fully supports FAIR principles for research data.
What You May Have Missed at AACC 2018 White Paper - Kalorama InformationBruce Carlson
Each year the American Association for Clinical Chemistry draws tens of thousands of lab professionals and in vitro diagnostic vendors to one place. Kalorama Information was there and noted major developments at the meeting in this White Paper. Major themes of scientific sessions, new products from lab and IVD vendors are included.
Dr. Jorge Garrido - Cost Effective Influenza Sampling Strategies for PigsJohn Blue
Cost Effective Influenza Sampling Strategies for Pigs - Dr. Jorge Garrido, from the 2017 Allen D. Leman Swine Conference, September 16-19, 2017, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2017-leman-swine-conference-material
Dr. Jorge Garrido - Cost Effective Influenza Sampling Strategies for PigsJohn Blue
Cost Effective Influenza Sampling Strategies for Pigs - Dr. Jorge Garrido, from the 2017 Allen D. Leman Swine Conference, September 16-19, 2017, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2017-leman-swine-conference-material
Development of quality control assays for cell-based medicinal products (ISCT...Quality Assistance s.a.
Dr. Fabian Vandermeers from Quality Assistance spoke on Development of quality control assays for cell-based medicinal products at ISCT 2017 in London.
For more information on this topic, visit: http://www.quality-assistance.com/analytical-services/CBMPs
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Molecular QC: Using Reference Standards in NGS PipelinesCandy Smellie
Since its inception, next-generation sequencing has found utility in a diverse set of industries, from biomarker discovery in pharma to ancestral identification in archeology. Across the board, NGS has the advantage of allowing us to answer questions that require a lot of data. Next-generation sequencing provides orders of magnitude more data than traditional Sanger sequencing as hundreds of “lanes” analyzed in parallel vs. hundreds of millions of “clusters” which allows for many samples to be multiplexed on a single-run.
By starting with different genetic material and following specific experimental workflows, NGS can be applied to many applications.
Here we focus on DNA resequencing applications, which implies the data generated will be compared to an existing reference sequence (such as the human genome). Specifically, we’ll focus on how we can analyze patient-derived material to identify onco-relevant mutations including single-nucleotide variants, insertions-deletions, copy number variants and translocations. We’ll also focus on how known reference standards have been shown to be vital in ensuring data generated from NGS assays is accurate and reproducible.
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxRASHMI M G
Abnormal or anomalous secondary growth in plants. It defines secondary growth as an increase in plant girth due to vascular cambium or cork cambium. Anomalous secondary growth does not follow the normal pattern of a single vascular cambium producing xylem internally and phloem externally.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
More Related Content
Similar to LQAS-based surveillance of antimicrobial resistance
Title: Diagnostics in Veterinary Oncology
Presented by: Ariana Verrilli, DVM, DACVIM (Oncology)
Description: This session will discuss the various tests currently available in veterinary oncology, from cytology and histopathology to DNA sequencing and genetic testing. We will review the pros and cons of multiple tests, the best use for each test, and how to interpret results. We will also review sample submissions and specific lab requirements as appropriate.
AMP-Based Variant Classification with VSClinicalGolden Helix
Evaluating somatic variants according to the cancer AMP guidelines can be an extensive process. In addition to the standard collection of all available, clinical evidence for any biomarkers, there is a need to define treatment options following final classification. Even the most adept clinicians familiar to the guidelines suffer from this arduous process and thus need a standardized approach for classifying, interpreting and reporting variants according to the AMP guidelines. VSClinical’s new AMP workflow alleviates these complexities by providing an automated workflow that captures and reports on all critical data present. With the VSClinical AMP workflow, users can also customize clinical reports to reflect your lab’s preferences and branding. This webcast will provide a simple AMP guideline-based demonstration from a user perspective with multiple examples of simple report customizations from the VSClinical interpretation hub.
What you will learn in this webcast:
How VSClinical integrates the tier system to evaluate somatic mutations according to the AMP guidelines, with a focus on SNPs, InDels, CNVs and fusions
Automating the AMP guidelines using Golden Helix CancerKB and lab-specific knowledge databases to streamline variant classifications
Multiple report examples to demonstrate simple Word-based report customization capability
Overall, VSClinical enables labs to test for both germline and somatic variants according to the ACMG and AMP guidelines in an automated fashion and allows users to obtain consistent and accurate results.
Using reference materials to meet validation & verification requirements for ...Candy Smellie
Bio-Specimens used in Molecular Diagnostics
Most clinical tissue samples are preserved in FFPE
FFPE samples are now being used for molecular diagnostic testing
FFPE based studies: every specimen is different in terms of % tumor contribution to the specimen and % mutation contribution to the tumor
External Quality Assessment Proficiency Testing Scheme
Therapeutic choices are made based upon these results
False positive and false negative results are detrimental to the patient
Validation occurs across multiple areas of the clinical laboratory. Validation can include equipment, reagents, operators, platforms. Two of the key areas are test and platform validation.
Test development includes:
Establishing protocol
Optimising performance
Determining pooling parameters
Using synthetic variants to compare tools and facilitate optimisation
Test validation includes:
Determine parameters
First tests developed carry highest validation requirements
Changes to tests must follow re-validation required against existing test
Platform validation
Cumulative performance data established
Determine confidence intervals
Track and validate software versions
Changes to platform must follow re-validation required against existing platform
Is insourcing NGS testing worth it?
Dartmouth-Hitchcock has experienced nearly 40% savings by bringing NGS testing in-house. A recent AMP study using non-small cell lung cancer as an example cites $2.7 million in anticipated savings.
In-house NGS testing is the foundation of any modern precision medicine program. It can have a profound effect on patient care. And, as these examples show, a strong business case can be made.
How have Dartmouth-Hitchcock and other progressive institutions been so successful despite myriad challenges?
Join us for a webinar on May 31st at 12pm ET as Eric Loo, MD (Dartmouth-Hitchcock) and Rakesh Nagarajan, MD, PhD (PierianDx) explore answers to this question and more.
In this webinar you will learn:
How recent precision medicine trends are driving strong market growth for clinical NGS and other complex molecular testing.
How to make a strong business case for in-house NGS testing.
Challenges your institution is likely to face by insourcing.
Blueprints for overcoming these challenges, including reimbursement.
Living in a world of federated knowledge challenges, principles, tools and ...Valery Tkachenko
Over years a multitude of chemical formats and approaches were created to address various aspects of handling chemical information and building databases of chemical knowledge. As a result the current state of this landscape is severely affected by the lack of well-accepted and community-recognized formats, protocols, metadata standards, validation routines and standards in handling, storing and representation, lack of open toolkits which conform to the same standards as well as the lack of platforms which allow interactive and collaborative work to solve all the above problems. While such organizations as RDA and IUPAC as well as some government agencies and institutes are concerned and trying to address the problem it is still a severe pain point. In this presentation we will talk about our experience of building a federated knowledgebase called Open Science Data Repository which supports deposition of raw and structured chemical and analytical data in various formats, runs validation and standardization protocols, is build in a highly modular way that allows using both its API and its components in a Cloud or to be deployed on premises behind firewalls and supports a variety of use cases including collaborative data curation, rich analytics and visualization, real-time machine learning, formats conversion and preparing depositions into PubChem and ChemSpider from a variety of sources and fully supports FAIR principles for research data.
What You May Have Missed at AACC 2018 White Paper - Kalorama InformationBruce Carlson
Each year the American Association for Clinical Chemistry draws tens of thousands of lab professionals and in vitro diagnostic vendors to one place. Kalorama Information was there and noted major developments at the meeting in this White Paper. Major themes of scientific sessions, new products from lab and IVD vendors are included.
Dr. Jorge Garrido - Cost Effective Influenza Sampling Strategies for PigsJohn Blue
Cost Effective Influenza Sampling Strategies for Pigs - Dr. Jorge Garrido, from the 2017 Allen D. Leman Swine Conference, September 16-19, 2017, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2017-leman-swine-conference-material
Dr. Jorge Garrido - Cost Effective Influenza Sampling Strategies for PigsJohn Blue
Cost Effective Influenza Sampling Strategies for Pigs - Dr. Jorge Garrido, from the 2017 Allen D. Leman Swine Conference, September 16-19, 2017, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2017-leman-swine-conference-material
Development of quality control assays for cell-based medicinal products (ISCT...Quality Assistance s.a.
Dr. Fabian Vandermeers from Quality Assistance spoke on Development of quality control assays for cell-based medicinal products at ISCT 2017 in London.
For more information on this topic, visit: http://www.quality-assistance.com/analytical-services/CBMPs
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Molecular QC: Using Reference Standards in NGS PipelinesCandy Smellie
Since its inception, next-generation sequencing has found utility in a diverse set of industries, from biomarker discovery in pharma to ancestral identification in archeology. Across the board, NGS has the advantage of allowing us to answer questions that require a lot of data. Next-generation sequencing provides orders of magnitude more data than traditional Sanger sequencing as hundreds of “lanes” analyzed in parallel vs. hundreds of millions of “clusters” which allows for many samples to be multiplexed on a single-run.
By starting with different genetic material and following specific experimental workflows, NGS can be applied to many applications.
Here we focus on DNA resequencing applications, which implies the data generated will be compared to an existing reference sequence (such as the human genome). Specifically, we’ll focus on how we can analyze patient-derived material to identify onco-relevant mutations including single-nucleotide variants, insertions-deletions, copy number variants and translocations. We’ll also focus on how known reference standards have been shown to be vital in ensuring data generated from NGS assays is accurate and reproducible.
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxRASHMI M G
Abnormal or anomalous secondary growth in plants. It defines secondary growth as an increase in plant girth due to vascular cambium or cork cambium. Anomalous secondary growth does not follow the normal pattern of a single vascular cambium producing xylem internally and phloem externally.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...Wasswaderrick3
In this book, we use conservation of energy techniques on a fluid element to derive the Modified Bernoulli equation of flow with viscous or friction effects. We derive the general equation of flow/ velocity and then from this we derive the Pouiselle flow equation, the transition flow equation and the turbulent flow equation. In the situations where there are no viscous effects , the equation reduces to the Bernoulli equation. From experimental results, we are able to include other terms in the Bernoulli equation. We also look at cases where pressure gradients exist. We use the Modified Bernoulli equation to derive equations of flow rate for pipes of different cross sectional areas connected together. We also extend our techniques of energy conservation to a sphere falling in a viscous medium under the effect of gravity. We demonstrate Stokes equation of terminal velocity and turbulent flow equation. We look at a way of calculating the time taken for a body to fall in a viscous medium. We also look at the general equation of terminal velocity.
Toxic effects of heavy metals : Lead and Arsenicsanjana502982
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
Phenomics assisted breeding in crop improvementIshaGoswami9
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
LQAS-based surveillance of antimicrobial resistance
1. Lot Quality Assurance Sampling
A tool for surveillance of antimicrobial resistance?
F R AN K VAN L E T H
A S S O C I A T E P R O F E S S O R O F G L O B A L H E A L T H
A M S T E R D A M U N I V E R S I T Y M E D I C A L C E N T E R S , L O C A T I O N A M C , U N I V E R S I T Y O F A M S T E R D A M
A M S T E R D A M I N S T I T U T E F O R G L O B A L H E A L T H A N D D E V E L O P M E N T
10. www.aighd.org
AMR surveillance: A solution
10
Laboratory based
AMR surveillance
Conventional LQAS
Selection bias Representative
Population based
Copyright: Massachusetts Biotechnology Council
12. www.aighd.org
Lot Quality Assurance Sampling (LQAS)
Derived from setting of manufacturing
◦ Quality assurance strategy
Main question: Is the threshold for ”adequate quality” met?
Assessment based on small samples from well-defined batches of goods
12
14. www.aighd.org
LQAS-based AMR surveillance
Done in a classification framework
Is the AMR prevalence in the population above or below x %
Framework does not include issues on power or statistical significant difference
◦ Use concept of misclassification
Lot can be any well-defined grouping
◦ Region
◦ Facility
◦ Subpopulation
Classification “high AMR” should lead to an intervention
14
A critical issue in the control of antimicrobial resistance is the measurement of its prevalence. There is a loud call to improve AMR surveillance to inform policies and antimicrobial stewardship.
The discussion is guided by WHO that produces the GLASS guidelines. These guideline focus on a laboratory-based AMR surveillance, in which many countries now invest. Although the document mentions the need for population-based surveillance, its core is really on laboratory-based surveiilance
Laboratory-based surveillance is potentially biased. Strains for drug sensitivity testing come from clinical care, where submission of specimens is far from random. However, therapeutic guideliens, inclusign those for empirical treatment in the outpatient setting, are often defined by assessing the collective antibiograms form this laboratory surveillance system
Population-based surveillance in which submission of strains is systematic and from well-defined clinical syndromes, are much better placed for guideline development
However, the sample size is in general large and can increase rapidly with improved precision
This preclused timely results and assessment of local variations in AMR prevalence
We therefore focuses on a sampling technique that could overcome this major hurdles
LQAS is a strategy that is already decades old and originates from the setting of manufacturing
It is quality assurance strategy that assesses if a batch g goods passes a predefined quality threshold
The assessment is based on small random samples from the larger batch
The batch or lot is a well defined grouping of items.
A small sample is taken with a predetermined size
All items in the sample are assessed for quality parameters
If more items than a predefined number fail the quality threshold then the entire batch or lot is rejected
If not, the entire batch or lot is accepted
This strategy is with an classification frame work
It answers the question: …...........
Discussions of statistically significant difference between lots and power are not in place
Instead there is a strong emphasis on the probability of misclassification
The wonderful thing is that a lot can be any well-defined grouping making it a very versatile strategy
The underlying idea of this approach is that classification of high AMR should lead to an intervention. If you are not willing to do anything, then you do not need to measure it
A classification framework incorporates the concept of misclassification
It should be determined how much that can be and whether classifying a true low resistance as high is just as undesired as classifying a true high resistance as low
In all the following slides we perceived the later situation as less desirable and set a maximum of 5%, while for the former situation we set a maximum of 10%
Typical LQAS sample sizes in which the set assumptions on misclassification of 5% and 10% are met are listed here
We have used these definition and sample sizes in the work that follows
We used a conventional AMR survey in outpatients in primary care in Indonesia to validate the LQAS methodology.
The survey gave us a true AMR prevalence of 13 antibiotics.
This can be interpreted as 13 LOTS with a known AMR prevalence
For each of these 13 lots we drew 1000 times the sample size required for different LQAS definitions
We thereby obtained 1000 LQAS classifications (high or low) for each LOT and each LQAS definition
Given that we knew the true AMR prevalence in the LOT, we could count the number of times the classification was correct
These are operator curves
On the y-axis we plot how often is the lot classified as high resistance
On the x-axis is the true prevalence of the LOT
The curves correspond to different LQAS definition.
With a true AMR prevalence below the lower limit of the LQAS definition, there is a very small probability classifying the lot as high prevalence
Similarly, with a true AMR prevalence above the upper limit of the LQAs definition, there is a very large probability of classifying the lot as high prevalence
In between there is potential misclassification.
Sensitivity is defined as correctly identifying high prevalence of AMR, while specificity if defined as correctly identifying low prevalence of AMR.
These test characteristics show that LQAS can very well identify areas with high AMR prevalence
Each lot gets an LQAS classification for each antibiotic tested.
This opens the door for the identification of local variations between lots.
In a conventional AMR survey, you will have a single prevalence estimate for the entire survey population.
The time for an LQAS classification varied between 45 and 100 days
Ensuring a sample size that accommodates different LQAS definition provides the opportunity for titration.
Looking at levofloxacin, the lot is classified as high resistance in every LQAS definition
That fits with the very high resistance found in the convectional survey of over 60%
Ensuring a sample size that accommodates different LQAS definition provides the opportunity for titration.
Looking at levofloxacin, the lot is classified as high resistance in every LQAS definition
That fits with the very high resistance found in the convectional survey of over 60%